Catatonia in psychiatric illnesses

The Medical Basis of Psychiatry: Third Edition

Volumn , Issue , 2008, Pages 455-470

  Dhossche, Dirk M ^a   Wachtel, Lee Elizabeth ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; Benzodiazepines; Catatonia; Childhood disintegrative disorder; Children; Delirium; Electroconvulsive treatment (ECT); Gamma aminobutyric acid (GABA); Mood disorder; Movement disorders; Prader Willi syndrome; Psychomotor abnormalities; Psychosis; Schizophrenia

Indexed keywords

EID: 84892362524     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-252-6_27     Document Type: Chapter

References (155)

1. Wernicke C. Grundriss der Psychiatrie in klinischen Vorlesungen (Parts I-III). Leipzig: Thieme, 1900.
2. Kahlbaum K. Die Katatonie oder das Spannungsirresein. Berlin: Verlag August Hirshwald, 1874.
3. Morrison J. Catatonia: retarded and excited types. Arch Gen Psychiatry 1973; 28:39-41.
4. Abrams R, Taylor M. Catatonia: a prospective clinical study. Arch Gen Psychiatry 1976; 33: 579-581.
5. Gelenberg A. The catatonic syndrome. Lancet 1976; 1: 1339-1341.
6. Braunig P, Kruger S, Shugar G. Prevalence and clinical significance of catatonic symptoms in mania. Compr Psychiatry 1998; 39:35-46.
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association, 1994.
8. Taylor M, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003; 160:1-9.
9. Fink M, Taylor M. Catatonia: subtype or syndrome in DSM? Am J Psychiatry 2006; 163:1875-1876.
10. Mahendra B. Where have all the catatonics gone? (Editorial). Psychol Med 1981; 11:669-671.
11. Beckmann H, Franzek E, Stöber G. Genetic heterogeneity in catatonic schizophrenia: a family study. Am J Med Genet (Neuropsychiatric Genetics) 1996; 67:289-300.
12. Stöber G, Saar K, Ruschendorf F, et al. Splitting schizophrenia: periodic catatonia susceptibility locus on chromosome 15q15. Am J Hum Genet 2000; 67:1201-1207.
13. Fink M, Taylor M. Catatonia. A clinician's guide to diagnosis and treatment. Cambridge: University Press, 2003.
14. Chalasani P, Healy D, Morriss R. Presentation and frequency of catatonia in new admissions to two acute psychiatric admission units in India and Wales. Psychol Med 2005; 35: 1667-1675.
15. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia: I: Rating scale and standardized examination. Acta Psychiatr Scand 1996; 93:129-136.
16. Ungavri G, Leung S, Shing F, Cheung H-K, Leung T. Schizophrenia with prominent catatonic features ("catatonic schizophrenia"). I. Demographic and clinical correlates in the chronic phase. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:27-38.
17. van der Heijden F, Tuinier S, Arts N, Hoogendoorn M, Kahn R, Verhoeven W. Catatonia: disappeared or under-diagnosed? Psychopathology 2005; 15:3-8.
18. Shorter E. Hysteria and catatonia as motor disorders in historical context. Hist Psychiatry 2006; 17:461-468.
19. Fricchione G, Cassem N, Hooberman D, Hobson D. Intravenous lorazepam in neuroleptic-induced catatonia. J Clin Psychopharmacol 1983; 3:338-342.
20. Rohland B, Carroll B, Jacoby R. ECT in the treatment of the catatonic syndrome. J Affect Disord 1993; 29:255-261.
21. Caroff S, Mann S, Francis A, Fricchione G. Catatonia. From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Publishing, Inc, 2004.
22. Fahn S, Marsden C, Calne D. Classification and investigation of dystonia. In: Marsden C, Fahn S, eds. Movement Disorders. London: Butterworths, 1987:332-358.
23. Gardos G, O' Cole J, Tarsy D. Withdrawal syndromes associated with antipsychotic drugs. Am J Psychiatry 1978; 135:1321-1324.
24. Jimenez-Jimenez F, Garcia-Ruiz P, Molina J. Drug-induced movement disorders. Drug Saf 1997; 16:180-204.
25. Trivedi H, Mendelowitz A, Fink M. Gilles de la Tourette from of catatonia: response to ECT. J ECT 2003; 19:115-117.
26. Karadenizli D, Dilbar N, Bayam G. Gilles de la Tourette syndrome response to electroconvulsive therapy. J ECT 2005; 21:246-248.
27. Hermesh H, Hoffnung R, Aizenberg D, Molcho A, Munitz H. Catatonic signs in severe obsessive compulsive disorder. J Clin Psychiatry 1989; 50:303-305.
28. Elia J, Dell M, Friedman D, et al. PANDAS with catatonia: a case-report. Therapeutic response to lorazepam and plasma-pheresis. J Am Acad Child Adolesc Psychiatry 2005; 44: 1145-1150.
29. Ayd F. A survey of drug-induced extrapyramidal reactions. JAMA 1961; 175:102-108.
30. Fink M. Recognizing NMS as a type of catatonia. Neuropsychi-atry Neuropsychol Behav Neurol 1995; 8:75-67.
31. Fink M, Taylor M. Neuroleptic malignant syndrome is malignant catatonia, warranting treatments efficacious for cata-tonia. Progr Neuropsychopharmacol Biol Psychiatry 2006; 30: 1182-1183.
32. White D. Catatonia and the neuroleptic malignant syndrome-a single entity? Br J Psychiatry 1992; 161.
33. Woodbury M, Woodbury M. Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome. J Am Acad Child Adolesc Psychiatry 1992; 31: 1161-1164.
34. Hem E, Andreassen O, Robasse J-M, Vatnaland T, Opjodsoen S. Should catatonia be part of the differential diagnosis of coma? Nord J Psychiatry 2005; 59: 528-530.
35. Benegal V, Hingorani S, Khanna S. Idiopathic catatonia: validity of the concept. Psychopathology 1993; 26:41-46.
36. Freudenreich O, McEvoy J, Goff D, Fricchione G. Catatonic coma with profound bradycardia. Psychosomatics 2007; 48: 74-78.
37. Bender K, Feutrill J. Comatoid catatonia. Aust NZ J Psychiatry 2000; 34:169-170.
38. Fujii D, Ahmed I. Is psychosis a neurobiological syndrome? Can J Psychiatry 2004; 49:713-718.
39. Northoff G. What catatonia can tell us about "top-down" modulation: a neuropsychiatric hypothesis. Behav Brain Sci 2002; 25:555-604.
40. Carroll B, Thomas C, Jayanti K, et al. Treating persistent catatonia when benzodiazepines fail. Curr Psychiatry 2005; 4: 22-33.
41. Wilcox J. Cerebellar atrophy and catatonia. Biol Psychiatry 1991; 29:733-734.
42. Northoff G. Neuroimaging and neurophysiology. In: Caroff S, Mann S, Francis A, Fricchione G, eds. Catatonia. From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Publishing, 2004.
43. Carroll B. The universal field hypothesis of catatonia and neuroleptic malignant syndrome. CNS Spectrums 2000; 5: 26-33.
44. Carroll B, Goforth H. Catatonia due to general medical conditions. In: Caroff S, Mann S, Francis A, Fricchione G, eds. Cata-tonia: From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Press, 2004.
45. Leonhard K. The classification of endogenous psychoses. In: Robins E, ed. New York: Irvington Publications, 1979.
46. Pfuhlmann B, Franzek E, Stöber G, Cetkovich-Bakmas M, Beckman H. On interrater reliability for Leonhard's classification of endogenous psychoses. Psychopathology 1997; 30: 100-150.
47. Neumärker K-J. Leonhard and the classification of psychomotor psychoses in childhood and adolescence. Psychopathology 1990; 23:243-252.
48. Stöber G, Haubitz I, Franzek E, Beckmann H. Parent-of-origin effect and evidence for differential transmission in periodic catatonia. Psychiatr Genet 1998; 8:213-219.
49. Stöber G, Seelow D, Ruschendorf F, Ekici A, Beckmann H, Reis A. Periodic catatonia: confirmation of linkage to chromosome 15 and further evidence for genetic heterogeneity. Hum Genet 2002; 111:323-330.
50. Wing L, Shah A. Catatonia in autistic spectrum disorders. Br J Psychiatry 2000; 176:357-362.
51. Billstedt E, Gilberg C, Gilberg C. Autism after adolescence: population-based 13-to 22-year follow-up study of 120 individuals with autism diagnosed in childhood. J Autism Dev Disord 2005; 35:351-360.
52. Papadimitriou G, Dikeos D, Karadima G, et al. Association between the GABA(A) receptor alpha 5 subunit gene locus (GABRA5) and bipolar affective disorder. Am J Med Genet 1998; 81:73-80.
53. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996; 93:137-143.
54. Green A. Changes in gamma-aminobutyric acid biochemistry and seizure threshold. Ann NY Acad Sci 1986; 462:105-119.
55. Sanacora G, Mason G, Rothman D, et al. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 2003; 160:577-579.
56. Northoff G, Steinke R, Czcervenka C, et al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry 1999; 67:445-450.
57. Nisijima K, Ishiguro T. Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndrome. J Psychiatr Res 1995; 3: 233-244.
58. Roberts E. Adventures with GABA. Fifty years on. In: Martin D, Olsen R, eds. GABA in the Nervous System. The View at Fifty Years. Philadelphia, PA: Lippincott Williams & Wilkins, 2000:1-24.
59. Jackson J. Evolution and dissolution of the nervous system. In: Taylor J, ed. Selected writings of John Hughlings Jackson. London: Stapes, 1958:45-118.
60. Roberts E. Prospects for research on schizophrenia. An hypotheses suggesting that there is a defect in the GABA system in schizophrenia. Neurosci Res Program Bull 1972; 10: 468-482.
61. van Kammen DP. Gamma-aminobutyric acid (GABA) and the dopamine hypothesis of schizophrenia. Am J Psychiatry 1977; 134:138-143.
62. Keverne E. GABAergic neurons and the neurobiology of schizophrenia and other psychoses. Brain Res Bull 1999; 48:467-473.
63. Kalkman H, Loetscher E. GAD67: the link between the GABA-deficit hypothesis and the dopaminergic and glutamatergic theories of psychosis. J Neural Transm 2003; 110:803-812.
64. Emrich H, von Zerssen D, Kissling W, Moller H, Windorfer A. Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders. Archiv fur Psychiatrie und Nervenkrankheiten 1980; 229:1-16.
65. Petty F. GABA and mood disorders: a brief review and hypothesis. J Affect Disord 1995; 34:275-281.
66. Brambilla P, Perez J, Barale F, Schettini G, Soares J. GABAergic dysfunction in mood disorders. Mol Psychiatry 2003; 8:721-737.
67. Petty F, Kramer G, Fulton M, Moeller F, Rush A. Low plasma GABA is a trait-like marker for bipolar illness. Neuropsy-chopharmacology 1993; 9:125-132.
68. Hussman J. Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism (letter). J Autism Dev Disord 2001; 31:247-248.
69. Dhossche D, Applegate H, Abraham A, et al. Elevated plasma GABA levels in autistic youngsters: stimulus for a GABA hypothesis of autism. Med Sci Monitor 2002:PR1-6.
70. Dhossche D, Rout U. Are autistic and catatonic regression related? A few working hypotheses involving GABA, Purkinje cell survival, neurogenesis, and ECT. Int Rev Neurobiol 2006; 72:55-79.
71. Dimitropoulos A, Feurer I, Roof E, et al. Appetitive behavior, compulsivity, and neurochemistry in Prader-Willi Syndrome. Ment Retard Dev Dis 2000; 6:125-130.
72. Dhossche D, Song Y, Liu Y-M. Is there a connection between autism, Prader-Willi syndrome, catatonia, and GABA? Int Rev Neurobiol 2005; 71:189-216.
73. Decavel C, van den Pol A. GABA: a dominant neurotransmitter in the hypothalamus. J Comp Neurol 1990; 302:1019-1037.
74. Herman J, Cullinan W. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 1997; 20:78-84.
75. Engelmann M, Landgraf R, Wotjak C. The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited. Front Neuroendocrinol 2004; 25:132-149.
76. Zink M, Schmitt A, May B, Muller B, Braus D, Henn F. Differential effects of long-term treatment with clozapine or haloperidol on GABA transporter expression. Pharmacopsychi-atry 2004; 37:171-174.
77. Bhagwagar Z, Wylezinska M, Taylor M, Jezzard P, Matthews P, Cowen P. Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry 2004; 161:368-370.
78. Sanacora G, Mason G, Rothman D, Krystal J. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 2002; 159:663-665.
79. Tunnicliff G, Schindler N, Crites G, Goldenberg R, Yohum A, Malatynska E. The GABAA receptor complex as a target for fluoxetine action. Neurochem Res 1999; 24:1271-1276.
80. Baker G, Wong J, Yeung J, Coutts R. Effects of the antidepres-sant phenelzine on brain levels of gamma-aminobutyric acid (GABA). J Affect Disord 1991; 21:207-211.
81. McManus D, Baker G, Martin I, Greenshaw A, McKenna K. Effects of the antidepressant/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain. Biochem Pharmacol 1992; 43:2486-2489.
82. Mervaala E, Kononen M, Fohr J, et al. SPECT and neuropsy-chological performance in severe depression treated with ECT. J Affect Disord 2001; 66:47-58.
83. Lipcsey A, Kardos J, Prinz G, Simonyi M. Der Effect der electrokonvulsiven Therapie auf den GABA-Spiegel des Liquor cerebrospinalis. Psychiatrie, Neurologie, und medizinische Psycholologie Leipzig 1986; 38:554-555.
84. Pfleiderer B, Michael N, Erfurth A, et al. Effective electrocon-vulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatr Res: Neuroimaging 2003; 122:185-192.
85. Devenand D, Shapira B, Petty F, et al. Effects of electroconvul-sive therapy on plasma GABA. Convuls Ther 1995; 11:3-13.
86. Otani K, Ujike H, Tanaka Y, et al. The GABA type A receptor alfa 5 subunit gene is associated with bipolar I disorder. Neurosci Lett 2005; 381:108-113.
87. Addington A, Gornick M, Duckworth J, et al. GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD(67)), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol Psychiatry 2005; 10: 581-588.
88. Cook E, Lindgren V, Levental B, et al. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet 1997; 60:928-934.
89. Lauritsen M, Mors O, Mortensen P, Ewald H. Infantile autism and associated autosomal chromosome abnormalities: a register-based study and a literature survey. J Child Psychol Psychiatry 1999; 40:335-345.
90. Borgatti R, Piccinelli P, Passoni D, et al. Relationship between clinical and genetic features in "inverted duplicated chromosome 15" patients. Ped Neurol 2001; 24:111-116.
91. Bakker S, van der Meulen E, Buitelaar J, et al. A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am J Hum Genet 2003; 72:1251-1260.
92. Ebert M, Schmidt D, Thompson T, Butler M. Elevated gamma-aminobutyric acid (GABA) levels in individuals with either Prader-Willi syndrome or Angelman syndrome. J Neuropsychi-atry Clin Neurosci 1997; 9:75-80.
93. Odano I, Anezaki T, Ohkubo M, et al. Decrease in benzodi-azepine receptor binding in a patient with Angelman syndrome detected by iodine-123 iomazenil and single-photon emission tomography. Eur J Nucl Med 1996; 23:598-604.
94. DeLorey T, Handforth A, Anagnostaras S, et al. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci 1998; 18: 8505-8514.
95. Cook E, Courchesne R, Cox N, et al. Linkage-disequilibrium mapping of autistic disorders, with 15q11-13 markers. Am J Hum Genet 1998; 62:1077-1083.
96. Menold M, Shao Y, Wolpert C, et al. Association analysis of chromosome 15 GABAa receptor subunit genes in autistic disorder. J Neurogenet 2001; 15:245-259.
97. Nurmi E, Dowd M, Tadevosyan-Leyfer O, Haines J, Folstein S, Sutcliffe J. Exploratory subsetting of autism families based on savant skills improves evidence of genetic linkage to 15q11-13. J Am Acad Child Adolesc Psychiatry 2003; 42:856-863.
98. Shao Y, Cuccaro M, Hauser E, et al. Fine mapping of autistic disorder to chromosome 15q11-q13 by use of phenotypic subtypes. Am J Hum Genet 2003; 72:539-548.
99. Ma D, Whitehead P, Menold M, et al. Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. Am J Hum Genet 2005; 77:377-388.
100. Vincent J, Horike S, Choufani S, et al. An inversion inv(4)(p12-p15.3) in autistic siblings implicate the 4p GABA receptor gene cluster. J Med Genet 2006; 43:429-434.
101. Bemporad J, Bunton H. Catatonic episodes in childhood. Int J Child Psychotherapy 1972; 1:19-44.
102. de Sanctis S. Dementia praecocissima catatonica oder Kata-tonie des Fruhen Kinderalters? Folia Neurobiologica 1908-1909; 2:9-12.
103. Neumärker K-J. Classification matters for catatonia and autism in children. Int Rev Neurobiol 2006; 72:3-19.
104. Dhossche D, Bouman N. Catatonia in children and adolescents (letter). J Am Acad Child Adolesc Psychiatry 1997; 36: 870-871.
105. Dhossche D, Bouman N. Catatonia in an adolescent with Prader-Willi syndrome. Ann Clin Psychiatry 1997; 4:247-253.
106. Delay J, Deniker P. Drug-induced extrapyramidal syndromes. In: Vinken P, Bruyn O, eds. Handbook of Clinical Neurology; vol 6. New York: Elsevier, 1968.
107. Fink M. Neuroleptic malignant syndrome. One entity or two? Biolog Psychiatry 1996; 39:1-4.
108. Hermesh H, Aizenberg D, Weizman A. A successful electro-convulsive treatment of neuroleptic malignant syndrome. Acta Psychiatr Scand 1987; 75:237-239.
109. Mann S, Caroff S, Bleier H, Antelo E, Un H. Electroconvulsive therapy of the lethal catatonia syndrome. Convuls Ther 1990; 6:239-247.
110. Green W, Padron-Gayol M, Hardesty A, Bassiri M. Schizophrenia with childhood onset: a phenomenological study of 38 cases. J Am Acad Child Adolesc Psychiatry 1992; 31: 968-976.
111. Thakur A, Jagadheesan K, Dutta S, Sinha V. Incidence of cata-tonia in children and adolescents in a pediatric psychiatric clinic. Aust NZ J Psychiatry 2003; 37:200-203.
112. Ghaziuddin N, Kutcher S, Knapp P, et al. Practice parameter for use of electroconvulsive therapy with adolescents. J Am Acad Child Adolesc Psychiatry 2004; 43:1521-1539.
113. Carr V, Dorrington C, Schrader G, Wale J. The use of ECT for mania in childhood bipolar disorder. Br J Psychiatry 1983; 143:411-415.
114. Black D, Wilcox J, Stewart M. The use of ECT in children: case-report. J Clin Psychiatry 1985; 46:98-99.
115. Cizadlo B, Wheaton A. Case study: ECT treatment of a young girl with catatonia. J Am Acad Child Adolesc Psychiatry 1995; 34:332-335.
116. Slooter A, Braun K, Balk F, van Nieuwenhuizen O, van der Hoeven J. Electroconvulsive therapy of malignant catatonia in childhood. Ped Neurol 2005; 32:190-192.
117. Kakooza A, Stoppelbein L, Dhossche D. Psychosis in autism. In: Fujii D, Ahmed I, eds. The Spectrum of Psychotic Disorders: Neurobiology, Etiology and Pathogenesis. Cambridge: Cambridge University Press, 2006.
118. Realmuto G, August G. Catatonia in autistic disorder: a sign of comorbidity or variable expression. J Autism Dev Disord 1991; 21:517-528.
119. Dhossche D. Catatonia in Autistic Disorders (brief report). J Autism Dev Disord 1998; 28:329-331.
120. Zaw F, Bates G, Murali V, Bentham P. Catatonia, autism, and ECT. Dev Med Child Neurol 1999; 41:843-845.
121. Brasic J, Zagzag D, Kowalik S, et al. Progressive catatonia. Psychol Rep 1999; 84:239-246.
122. Hare D, Malone C. Catatonia and autism spectrum disorders. Autism 2004; 8:183-195.
123. Ghaziuddin M, Quinlan P, Ghaziuddin N. Catatonia in autism: a distinct subtype? J Intellect Disabil Res 2005; 49: 102-105.
124. Ohta M, Kano Y, Nagai Y. Catatonia in individuals with autism spectrum disorders in adolescence and early adulthood: a long-term prospective study. Int Rev Neurobiol 2006; 72: 41-54.
125. Cohen D. Towards a valid nosography and psychopathology of catatonia in children and adolescents. Int Rev Neurobiol 2006; 72:131-147.
126. Schieveld J. Case reports with a child psychiatric exploration of catatonia, autism, and delirium. Int Rev Neurobiol 2006; 72:195-206.
127. Fink M, Taylor M, Ghaziuddin N. Catatonia in autistic spectrum disorders: a medical treatment algorithm. Int Rev Neuro-biol 2006; 72:233-244.
128. Wachtel L, Kahng S, Dhossche D, Cascella N, Reti I. ECT for catatonia in an autistic girl. Am J Psychiatry, 2008, In Press.
129. Stoppelbein L, Greening L, Kakooza A. The importance of catatonia and stereotypies in autistic spectrum disorders. Int Rev Neurobiol 2006; 72:103-118.
130. Fombonne E. Prevalence of childhood disintegrative disorder. Autism 2002; 6:149-157.
131. Volkmar F, Cohen D. Disintegrative disorder or "late onset autism." J Child Psychol Psychiatry 1989; 30:717-724.
132. Holm V, Cassidy S, Butler M, et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993; 2:398-402.
133. Burd L, Vesely B, Martsolf J, Kerbeshian J. Prevalence study of Prader-Willi syndrome in North Dakota. Am J Med Genet 1990; 37:97-99.
134. Åkefeldt A, Gilberg C, Larson C. Prader-Willi syndrome in a Swedish rural county: epidemiological aspects. Dev Med Child Neurol 1991; 33:715-721.
135. Ehara H, Ohno K, Takeshita K. Frequency of the Prader-Willi Syndrome in the San-in district, Japan. Brain Dev 1995; 17:324-326.
136. Smith A, Egan J, Ridley G, et al. Birth prevalence of Prader-Willi Syndrome in Australia. Arch Dis Child 2003; 88: 263-264.
137. Woodage T, Deng Z, Prasad M, et al. A variety of genetic mechanisms are associated with the Prader-Willi Syndrome. Am J Med Genet (Neuropsychiatric Genetics) 1994; 54:219-226.
138. Angelman H. "Puppet" children. A report of three cases. Dev Med Child Neurol 1965; 7:681-688.
139. Wigren M, Hansen S. Rituals and compulsivity in Prader-Willi syndrome: profile and stability. J Intellect Disabil Res 2003; 47:428-438.
140. Clarke D. Prader-Willi syndrome and psychoses. Br J Psychiatry 1993; 163:680-684.
141. Boer H, Holland A, Whittington J, Butler J, Webb T, Clarke D. Psychotic illness in people with Prader-Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet 2002; 12:135-136.
142. Wigren M, Hansen S. ADHD symptoms and insistence on sameness in Prader-Willi syndrome. J Intellect Disabil Res 2005; 49:449-456.
143. Harris JC. Developmental Neuropsychiatry, Vol. II. Oxford: Oxford University Press, 1998:251-257.
144. Verhoeven W, Curfs L, Tuinier S. Prader-Willi syndrome and cycloid psychoses. Intellect Disabil Res 1998; 42: 455-462.
145. Vogels A, Matthijs G, Legius E, Devriendt K, Fryns J-P. Chromosome 15 maternal uniparental disomy and psychosis in Prader-Willi syndrome. J Med Genet 2003; 40: 72-73.
146. Joseph B, Egli M, Sutcliffe J, Thompson T. Possible dosage effect of maternally expressed genes on visual recognition memory in Prader-Willi Syndrome. Am J Med Genet (Neuropsychiatric Genetics) 2001; 105:71-75.
147. Abe K, Ohta M. Recurrent brief episodes with psychotic features in adolescence: periodic psychosis of puberty revisited. Br J Psychiatry 1995; 167:507-513.
148. Bartolucci G, Younger J. Tentative classification of neuropsy-chiatric disturbances in Prader-Willi syndrome. J Intellect Disabil Res 1994; 38:621-629.
149. Verhoeven W, Tuinier S. Prader-Willi syndrome: atypical psychoses and motor dysfunctions. Int Rev Neurobiol 2006; 72:119-130.
150. Carroll B, Goforth H. Medical catatonia. In: Caroff S, Mann S, Francis A, Fricchione G, eds. Catatonia. From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Publishing, Inc., 2004.
151. Lopez-Canino A, Francis A. Drug-induced catatonia. In: Caroff S, Mann S, Francis A, Fricchione G, eds. Catatonia. From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Publishing, Inc., 2004.
152. Dhossche D, Shah A, Wing L. Blueprints for the assessment, treatment, and future study of catatonia in autism spectrum disorders. Int Rev Neurobiol 2006; 72:267-284.
153. Dhossche D, Wing L, Ohta M, Neumärker K-J. Catatonia in Autism Spectrum Disorders. International Review of Neurobi-ology. Vol. 72. San Diego, California and London, UK: Elsevier Academic Press, 2006.
154. Abrams R. Electroconvulsive therapy. 4th ed. New York: Oxford University Press, 2002.
155. Bumke O. Lehrbuch der Geisteskrankheiten. 2nd ed. Bergmann, Munich, 1924.